Site Menu
Search Close Search
Search Close Search
Page Menu

Dale L. Greiner, PhD

Research Focus - Humanized Mice as Preclinical Models of Human Cancer

  • Analyzing preclinical models of the interactions between the human immune system and human cancer
  • Understanding how human tumors escape immune rejection
  • Developing approaches to modulate the tumor immune environment
  • Examining newly emerging checkpoint inhibitors for human cancer therapy

Representative Publication

Wang M, Yao LC, Cheng M, et al. Humanized mice in studying efficacy and mechanisms of PD-1 targeted cancer immunotherapy. FASEB J. 2018;32(3):1537-1549.

Read Publication

More Publications

In the News

Getting Results…
  • Convocation 2024: UMass Chan racing toward ambitious future

    Convocation 2024: UMass Chan racing toward ambitious future

    Four faculty members were honored with chancellor’s medals, and seven others were invested as named professors at the annual Convocation and Investiture celebration.

    Read more
  • UMass Chan kicks off 2024 academic year with weeklong Convocation celebration

    UMass Chan kicks off 2024 academic year with weeklong Convocation celebration

    Festivities kick off on Friday, Sept. 6, with the T.H. Chan School of Medicine White Coat Ceremony, welcoming the new class of medical students into the medical community.

    Read more
  • Six new endowed chairs named at UMass Chan Medical School

    Six new endowed chairs named at UMass Chan Medical School

    These highly accomplished faculty members have been appointed to endowed chairs at UMass Chan Medical School: Dale L. Greiner, PhD; Danny G. Winder, PhD; Elinor K. Karlsson, PhD; Jeannette M. Wolfe, MD; J. Kevin Donahue, MD; and John E. Harris, MD, PhD’05.

    Read more
  • UMass Medical School joins JDRF Center of Excellence in New England to advance type 1 diabetes research

    UMass Medical School joins JDRF Center of Excellence in New England to advance type 1 diabetes research

    Five UMass Medical School scientists from the UMass Diabetes Center of Excellence are part of the JDRF Center of Excellence in New England that launched Feb. 23. The goal of the is to create a cell replacement therapy that could treat and potentially cure type 1 diabetes.

    Read more